Drotrecogin alfa (activated): diffusion from clinical trials to clinical practice.
Mackenzie
A F
AF
D002986:Clinical Trials as Topic; D006801:Humans; D011364:Professional Practice; D011486:Protein C / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated